C4 Therapeutics, Inc. (CCCC)
USD 3.66
(-9.75%)
USD 3.66
(-9.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -106.83 Million | -105.93 Million | -86.96 Million | -67.24 Million | 55.61 Million | -16.98 Million |
| Net Income | -132.49 Million | -128.17 Million | -83.89 Million | -66.33 Million | -34.09 Million | -15.71 Million |
| Depreciation & Amortization | 7.73 Million | 1.67 Million | 1.49 Million | 1.61 Million | 1.59 Million | 1.27 Million |
| Deferred income taxes | 10.05 Million | - | 1.87 Million | 5.58 Million | 350 Thousand | 66 Thousand |
| Stock-based compensation | 27.23 Million | 30.01 Million | 21.51 Million | 3.43 Million | 1.64 Million | 582 Thousand |
| Change in working capital | -6.93 Million | -16.77 Million | -30.09 Million | -13.17 Million | 84.98 Million | -5.55 Million |
| Other non-cash items | -12.43 Million | 7.32 Million | 2.13 Million | 1.63 Million | 1.14 Million | 2.36 Million |
| Investing Cash Flow | 158.34 Million | 58.42 Million | -189.33 Million | -190.5 Million | -1.62 Million | 36.92 Million |
| Investments in PPE | -1.7 Million | -5.49 Million | -1.27 Million | -650 Thousand | -1.34 Million | -2.68 Million |
| Acquisitions | -160.05 Million | -63.91 Million | 188.05 Million | 189.85 Million | 63 Thousand | - |
| Investment purchases | -129.89 Million | -219.52 Million | -537.74 Million | -293.85 Million | -79 Million | -4.99 Million |
| Sales/Maturities of investments | 289.95 Million | 283.44 Million | 349.68 Million | 104 Million | 78.66 Million | 44.6 Million |
| Other Investing Activities | 160.05 Million | 63.91 Million | -188.05 Million | -189.85 Million | -271 Thousand | 39.61 Million |
| Financing Cash Flow | 45.48 Million | 1.14 Million | 171.4 Million | 348.93 Million | 244 Thousand | 1.96 Million |
| Debt repayment | -12.5 Million | - | - | -11.97 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -110 Thousand | - | - | -194 Thousand | -30 Thousand | -63 Thousand |
| Common Stock Issuance | 57.73 Million | 777 Thousand | 169.46 Million | 340.59 Million | 274 Thousand | 47 Thousand |
| Other Financing Activities | 368 Thousand | 370 Thousand | 1.93 Million | 32.47 Million | -30 Thousand | 1.91 Million |
| Accounts receivables | -10.32 Million | 4.24 Million | -1.23 Million | 139 Thousand | 81.81 Million | -84.94 Million |
| Accounts payables | 273 Thousand | -3.33 Million | -1.17 Million | 467 Thousand | 4.23 Million | 578 Thousand |
| Inventory | - | - | -2.62 Million | -1.58 Million | 2.17 Million | -2.22 Million |
| Other working capital | 3.11 Million | -17.69 Million | -25.05 Million | -12.2 Million | -3.23 Million | 81.02 Million |
| Cash at beginning of period | 29.75 Million | 79.4 Million | 184.3 Million | 93.12 Million | 38.88 Million | 16.98 Million |
| Cash at end of period | 126.59 Million | 33.03 Million | 79.4 Million | 184.3 Million | 93.12 Million | 38.88 Million |
| Capital Expenditure | -1.7 Million | -5.49 Million | -1.27 Million | -650 Thousand | -1.34 Million | -2.68 Million |
| Effect of forex changes on cash | -164 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 96.83 Million | -46.37 Million | -104.9 Million | 91.17 Million | 54.23 Million | 21.9 Million |
| Free Cash Flow | -108.54 Million | -111.43 Million | -88.24 Million | -67.89 Million | 54.26 Million | -19.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.66 Million | -17.71 Million | -28.36 Million | -34.75 Million | -132.49 Million | -27.03 Million |
| Depreciation & Amortization | -2.73 Million | 2.04 Million | 2.02 Million | 1.69 Million | 7.73 Million | 447 Thousand |
| Deferred income taxes | - | - | - | -20.87 Million | 10.05 Million | -472 Thousand |
| Stock-based compensation | 8.83 Million | 6.38 Million | 6.21 Million | 6.35 Million | 27.23 Million | 8.2 Million |
| Change in working capital | -9.22 Million | 5.86 Million | 3.35 Million | 3.4 Million | -6.93 Million | -13.49 Million |
| Other non-cash items | 3.66 Million | -2.79 Million | 10.53 Million | 20.16 Million | -12.43 Million | 1.65 Million |
| Investing Cash Flow | 162 Thousand | -11.7 Million | -53.39 Million | 31.94 Million | 158.34 Million | 57.72 Million |
| Investments in PPE | 13 Thousand | -197 Thousand | - | -157 Thousand | -1.7 Million | -600 Thousand |
| Acquisitions | - | - | - | -32.1 Million | -160.05 Million | -58.32 Million |
| Investment purchases | -68.56 Million | -67.22 Million | -107.74 Million | -37.87 Million | -129.89 Million | -31.94 Million |
| Sales/Maturities of investments | 68.71 Million | 55.71 Million | 54.35 Million | 69.98 Million | 289.95 Million | 90.26 Million |
| Other Investing Activities | 149 Thousand | -11.5 Million | -53.39 Million | 32.1 Million | 160.05 Million | 58.32 Million |
| Financing Cash Flow | 10.5 Million | 135 Thousand | 34.58 Million | 57.67 Million | 45.48 Million | -10.75 Million |
| Debt repayment | - | - | - | -12.5 Million | -12.5 Million | -11 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 20.1 Million | - | -109 Thousand | - | -110 Thousand | -16 Thousand |
| Common Stock Issuance | -10.37 Million | 135 Thousand | 34.6 Million | 57.67 Million | 57.73 Million | - |
| Other Financing Activities | 770 Thousand | 135 Thousand | 84 Thousand | -1000.00 | 368 Thousand | 263 Thousand |
| Accounts receivables | -9.17 Million | 12.43 Million | -1.79 Million | -11.3 Million | -10.32 Million | 528 Thousand |
| Accounts payables | 590 Thousand | -715 Thousand | 182 Thousand | 169 Thousand | 273 Thousand | -837 Thousand |
| Inventory | - | - | - | 1.65 Million | - | -2.61 Million |
| Other working capital | 874 Thousand | -5.84 Million | 4.97 Million | 14.53 Million | 3.11 Million | -10.57 Million |
| Cash at beginning of period | 73.11 Million | 89.65 Million | 126.59 Million | 60.97 Million | 29.75 Million | 48.16 Million |
| Cash at end of period | 63.09 Million | 73.11 Million | 89.65 Million | 126.59 Million | 126.59 Million | 64.42 Million |
| Capital Expenditure | 13 Thousand | -197 Thousand | - | -157 Thousand | -1.7 Million | -600 Thousand |
| Effect of forex changes on cash | - | - | - | 11 Thousand | -164 Thousand | - |
| Net cash flow / Change in cash | -10.02 Million | -16.54 Million | -36.93 Million | 65.61 Million | 96.83 Million | 16.26 Million |
| Free Cash Flow | -24.12 Million | -5.17 Million | -18.11 Million | -24.16 Million | -108.54 Million | -31.3 Million |
HLLY
FPLSF
HQY
VAGNF
3002
EUSP